Generic Name and Formulations:
Isoflurane; liq for inhalation.
Indications for FORANE:
Induction and maintenance of general anesthesia.
Adults and Children:
See full labeling. Individualize. Induction: inspired concentrations of 1.5–3% isoflurane usually produce surgical anesthesia in 7–10 minutes. Maintenance: surgical levels of anesthesia may be sustained with a 1–2.5% concentration when nitrous oxide is used concomitantly. An additional 0.5–1% may be required when isoflurane is given using oxygen alone. If added relaxation is required, supplemental doses of muscle relaxants may be used.
Hypersensitivity to halogenated agents. Susceptibility to malignant hyperthermia.
To be administered only by those experienced in general anesthesia. Have intubation, artificial ventilation, oxygen and circulatory resuscitation available. Monitor for perioperative hyperkalemia esp. in pediatric patients during post-op period and those with latent or overt neuromuscular disease (eg, Duchenne muscular dystrophy); cardiac arrhythmias and death may occur. Pediatric neurotoxicity risk with repeated or prolonged use. Pregnancy. Nursing mothers.
Caution with desiccated CO2 absorbents; replace before administration. Hyperkalemia with succinylcholine. Potentiates effects of muscle relaxants, esp. nondepolarizing muscle relaxants. MAC reduced by concomitant nitrous oxide.
Respiratory depression, hypotension, arrhythmias, shivering, nausea, vomiting, ileus, transient elevations in CSF pressure, blood glucose, creatinine, cholesterol, ALK, WBC; perioperative hyperkalemia, malignant hyperthermia.
Bottles (100mL, 250mL)—1
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|